Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 040490/0848 | |
| Pages: | 5 |
| | Recorded: | 10/26/2016 | | |
| Attorney Dkt #: | CAJ-001US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/18/2017
|
Application #:
|
14440001
|
Filing Dt:
|
04/30/2015
|
|
Publication #:
|
|
Pub Dt:
|
09/24/2015
| | | | |
|
Title:
|
COMBINATION OF AN ANTI-CANCER AGENT SUCH AS A TYROSINEKINASE INHIBITOR AND A STAT5 ANTAGONIST, PREFERABLY A THIAZOLIDINEDIONE, FOR ELIMINATING HEMATOLOGIC CANCER STEM CELLS IN VIVO AND FOR PREVENTING HEMATOLOGIC CANCER RELAPSE
|
|
|
Assignee
|
|
|
|
|
| 25, RUE LEBLANC |
| BATIMENT "LE PONANT" |
| PARIS, FRANCE 75015 |
|
|
Correspondence name and address
|
| |
NELSON MULLINS RILEY & SCARBOROUGH LLP
|
| |
ONE POST OFFICE SQUARE
|
| |
FL 30
|
| |
BOSTON, MA 02109
|
Search Results as of:
06/04/2024 11:56 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
